Suven Pharmaceuticals Ltd
BSE: 543064
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 359.89-36.6% | 567.55+17.9% | 481.58-3.3% | 497.79+2.9% | 483.58+46.5% | 330.17+19.9% | 275.39+16.7% | 236.06 |
| Other Income | 12.16+1639.2% | -0.79-112.9% | 6.12-76.7% | 26.30+100.8% | 13.10+97.6% | 6.63-56.3% | 15.18+13.0% | 13.43 |
| Total Income | 372.05-34.4% | 566.76+16.2% | 487.70-6.9% | 524.09+5.5% | 496.68+47.5% | 336.80+15.9% | 290.57+16.5% | 249.49 |
| EXPENSES | ||||||||
| Expenditure | 369.84-25.1% | 493.81+18.3% | 417.41+3.5% | 403.37-3.4% | 417.54+48.9% | 280.48+59.4% | 175.97+18.3% | 148.81 |
| Tax | 0.80-96.3% | 21.88+20.6% | 18.14-31.4% | 26.43+43.1% | 18.47+54.2% | 11.98-57.6% | 28.25+16.0% | 24.35 |
| PROFIT | ||||||||
| PBT | 2.21-96.1% | 56.44-13.7% | 65.43-45.8% | 120.72+69.9% | 71.04+26.1% | 56.32-50.9% | 114.60+13.8% | 100.68 |
| Net Profit | 1.41-95.9% | 34.56-26.9% | 47.29-49.8% | 94.29+79.4% | 52.57+18.6% | 44.34-48.7% | 86.35+13.1% | 76.33 |
| KEY METRICS | ||||||||
| OPM % | 7.36%-10.27pp | 17.63%-2.70pp | 20.33%-5.96pp | 26.29%+6.42pp | 19.87%-0.48pp | 20.35%-9.93pp | 30.28%-0.85pp | 31.13% |
| NPM % | 0.38%-5.72pp | 6.10%-3.60pp | 9.70%-8.29pp | 17.99%+7.41pp | 10.58%-2.59pp | 13.17%-16.55pp | 29.72%-0.87pp | 30.59% |
| EPS | 0.04-95.6% | 0.90-27.4% | 1.24-49.6% | 2.46+78.3% | 1.38-20.7% | 1.74-48.7% | 3.39+13.0% | 3.00 |
Corporate Events
Board MeetingCOHANCE
202617Sep
Board Meeting
The Eighth Annual General Meeting of the Members of Cohance …
BSE Filing ↗ Board MeetingCOHANCE
20263Sep
Board Meeting
The Investment, Banking and Authorisations Committee (IBA Co…
BSE Filing ↗ Board MeetingCOHANCE
20265Aug
Board Meeting
The meeting of the Board of Directors will be held to consid…
BSE Filing ↗ Board MeetingCOHANCE
202623Jul
Board Meeting
The Nomination and Remuneration Committee approved the in-pr…
BSE Filing ↗ Board MeetingCOHANCE
202412Nov
Board Meeting
Consider and approve the Un-audited Financial Results (Stand…
BSE Filing ↗ Board MeetingCOHANCE
20245Feb
Board Meeting
To consider and approve Un-audited Financial Results (Standa…
BSE Filing ↗ Board MeetingCOHANCE
20239Nov
Board Meeting
To consider and approve the Un-audited Financial Results (St…
BSE Filing ↗ Board MeetingCOHANCE
20238Aug
Board Meeting
Consider and approve the Un-audited Financial Results (Stand…
BSE Filing ↗